Welcome to YLOAN.COM
yloan.com » Marketing » Biotechnology Pharmaceutical Market in US 2009-2013
Marketing Advertising Branding Careers-Employment Change-Management Customer Service Entrepreneurialism Ethics Marketing-Direct Negotiation Outsourcing PR Presentation Resumes-Cover-Letters Sales Sales-Management Sales-Teleselling Sales-Training Strategic-Planning Team-Building Top7-or-Top10-Tips Workplace-Communication aarkstore corporate advantages development collection global purchasing rapidshare grinding wildfire shipping trading economy wholesale agency florida attorney strategy county consumer bills niche elliptical

Biotechnology Pharmaceutical Market in US 2009-2013

Pharmaceutical Biotechnology refers to drugs, medicines or vaccines developed through

biotechnology such as recombinant DNA technology, combinatorial chemistry, gene therapy, and monoclonal antibodies. The biotechnology-based drugs or genetically-engineered drugs are produced by microorganisms such as bacteria or biological substances such as enzymes.

According to TechNavio, the market for Pharmaceutical Biotechnology in the US is forecast to reach $60.1 billion in 2013 from $44.7 billion in 2009; thus, growing at a CAGR of 7.7 percent over the period.

Pharmaceutical Biotechnology represents the fastest growing sector in the Pharmaceutical market in the US. This could be attributed to the entrants of new generation biotechnology drugs, which are highly potential and effective in treating a wide range of diseases including age-related diseases. Further, there is an increasing demand for customized treatment, as a result of which, many biotechnology pharmaceutical companies are engaging in the development of drugs targeted at specific genes. Besides, the R&D spending by pharmaceutical companies has risen steadily.

However, the introduction of new drugs in Pharmaceutical Biotechnology market in the US continues to become more difficult due to extensive research costs and high consumption of time. Further, the stringent regulatory approval process of new drugs continues to be the barrier to entry into this US market.


This report forecasts the size of the Pharmaceutical Biotechnology market over the period 2009- 2013. It also highlights the scope of the market in US, along with trends, drivers, growth inhibitors and a few major vendors of the market.

For further information on this report please visit: http://www.technavio.com/content/europe-dash-navigation-systems-market-2009-2013

Biotechnology Pharmaceutical Market in US 2009-2013

By: Infiniti Research Limited
Europe In-Dash Navigation Systems Market 2009-2013 Article Marketing Strategies: Selecting The Best Sites & Ezines For Your Article Marketing Campaign Magnum Marketing Ltd : Marketing campaigns with a difference Book Marketing - Expert Tips & Ideas 2 Ways To Come Up With A Profitable Forex Trading System Just Because You Self Published, Do You Have To Self Market? Free Article Marketing Course To Increase Google Rankings Obtaining Mailist Lists As A Crucial Element Of Your Marketing Plan The Marketing Power of Facebook Why Bulk Mailing Is A Vital Marketing Strategy Seeking Out The Best Website Promotion And Marketing Ideas Available Out There Profiting From Day Trading Forex Currency Three Easy Steps To Increase Profits Out Of Your Trade Show Giveaways
print
www.yloan.com guest:  register | login | search IP(216.73.216.60) California / Anaheim Processed in 0.017472 second(s), 5 queries , Gzip enabled , discuz 5.5 through PHP 8.3.9 , debug code: 14 , 2154, 66,
Biotechnology Pharmaceutical Market in US 2009-2013 Anaheim